IMMUNOLOGICAL STUDIES ON A C POLYSACCHARIDE COMPLEX OF GROUP A STREPTOCOCCI HAVING A DIRECT TOXIC EFFECT ON CONNECTIVE TISSUE by Schwab, John H. & Cromartie, William J.
IMMUNOLOGICAL STUDIES ON A C POLYSACCHARIDE COMPLEX 
OF  GROUP  A  STREPTOCOCCI HAVING  A  DIRECT 
TOXIC EFFECT ON  CONNECTIVE TISSUE* 
BY JOHN H. SCHWAB, PH.D., AND WILLIAM J.  CROMARTIE, M.D. 
(From the Departments  of Bacteriology and Medicine,  University  of North  Carolina, 
School of Medicine, Chapel Hill) 
(Received for publication, October 26, 1959) 
Group  A  streptococci contain  a  toxic cellular component which  produces 
chronic remittent and intermittent nodular lesions in  the dermal connective 
tissue of rabbits following a single intradermal injection (1). The toxic material 
appears to have a direct toxic effect  on the dermal connective tissue, producing 
areas of fibrinoid necrosis and an associated granulomatous reaction. After a 
single injection of this material recurrent acute lesions have been observed to 
occur as late as 53 days after the injection, suggesting that the toxic material is 
capable of remaining in the tissues and of producing repeated injury over a long 
period of time.  The association of Group A  streptococci with certain of the 
chronic diseases of connective tissue, such as rheumatic fever, combined with 
the nature of the experimental connective tissue lesion, described here and else- 
where (1,  2) warrant further investigation of the properties of this toxic sub- 
stance. 
Recent studies  have revealed that  the  toxic material  is a  macromolecular 
complex of the  group-specific C  polysaccharide and  a  peptide;  the polysac- 
charide moiety being an  essential  part  of the  toxic activity  (3).  Additional 
studies have demonstrated that  the ability to produce the connective tissue 
lesion is related to the physical dimensions of the polysaccharide-peptide com- 
plex. The isolated polysaccharide hapten with a molecular weight of about 8,000 
displays no toxic activity. At the other extreme, large cell wall fragments are 
toxic but are less active on a weight basis than fragments of intermediate size 
(4). This communication presents immunological data showing that this toxic 
cellular component can be neutralized by antibodies directed against the C poly- 
saccharide  moiety. 
Materials and Methods 
Extraction of Cells.--The streptococci  were grown as previously  described (1). Cells from 1 
L of an 18 hour broth culture were collected by centrifugation, washed 2 times with equal 
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volumes of cold saline, and re.suspended in 15 ml. pH 7.0 phosphate buffer. This suspension 
was then subjected to I hour sonic oscillation in a Raytheon 9 kc. sonic oscillator. The sonicate 
was centrifuged at 36#00 G for 30 minutes in a Spinco No. 40 rotor, and the supernate filtered 
through a Selas 02 filter to yield the sterile crude extract. 
Fractionation of the crude extract was carried out as before, using the same terminology 
(3). Thus, the toxic cellular component was partially purified by collecting the sediment from 
the crude extract after centrifugation at 75,000 G for 1 hour. This sediment was washed 2 times 
with pH 7.0 buffer and labeled 75p60-3. It was stored at --20°C. Further purification was 
achieved by subjecting the 75p60-3 suspension to moving boundary  electrophoresis  in  a Tiselius 
cell. The slowest moving fraction was collected and labeled electrophoretic trailing fraction (3). 
Immunlzcaion of Rabbi~s.~Rabbits  were immunized according to the schedule and dosage 
of McCarty and Lancefield (5). The vaccine consisted of heat-killed, pepsin-treated  strep- 
tococci of strain C203/29/4,  Group A, Type 3, (avirulent). The animals were bled from the 
heart 7 days after the last injection and 2 days prior to challenge. 
Organisms.--The  following Group A streptococci were kindly provided by Dr.  Rebecca 
Lancefield: Type 1, strains K43 original C and K43 variant C; Type 3 strain C203/29/4, 
original C, (no M-avimlent),  strain C203/42/3, original C (good M-virulent), and strain B455, 
variant C. Strain K43, variant C was derived from K43 original C. Strain B455 was derived 
from the same stock as C203/29. All of these strains have Type 1 T antigen (5). 
The rabbits were immunized with the Type 3, C203/29/4 strain, original C. The antiserum 
was absorbed with strain B455, variant C. The sonic extracts and fractions used for the chal- 
lenge of immunized animals and in vitro neutralization studies were prepared from a Type I 
strain used in previous studies. 
Immunochemical Andysis.--The quantitative precipitin determinations were carried out 
by the method described by Kabat and Mayer (6) and the nitrogen was determined by nes- 
slerization. 
His~dogical Stad/es.--Tissue sections were prepared from formalin-fixed  tissues and stained 
with hematoxylin and eosin. 
Es~imaZion of Toxic Aai*i¢y.--Quantitation  of toxicity was performed by dividing the maxi- 
mum area, in millimeters, of the dermal lesion by the time required, in days, for the gross ap- 
pearance of the lesion (3). This is referred to as the index value. The index values recorded in 
this paper represent the average of at least 6 rabbits. 
RESULTS 
In Vivo Studies.~ 
Six rabbits, hyperimmunized to yield a high anti-C titer, were injected intradermally with 
a 75p60-3 fraction of the sonic extract of a Type i organism. The partially purified fraction was 
used to reduce the complications of hypersensitivity, by eliminating several antigenic com- 
ponents of the crude extract. The animals received 0.2 ml. of the undiluted material on one 
flank and a 1/10 dilution in buffer on the opposite side. Six control rabbits were injected simi- 
larly. 
The gross and microscopic features of the reaction in normal rabbits have 
been described in detail elsewhere (1, 2). The initial erythema and edema were 
similar in the immunized and control groups during the first 24 hours. In the 
non-immunized  control group this initial response subsided to a negative or very 
minimal reaction within 2 to 3 days, and then evolved into the typical multi- 
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ment  was  approximately 70  ×i 40  mm.  The immunized animals  developed 
single small nodules averaging 20 X  15 ram. at the sites of injection which sub- 
sided over a period of 10 to 18 days. The multinodular lesion did not occur in 
these immune animals nor were any exacerbations observed during daily in- 
spection over a period of 50 days. Data comparing the index values for these 
two groups, seen in Table I, demonstrate the development of a definite active 
immunity. It should be pointed out that the rabbits were immunized with the 
C203/29/4 strain of a Type 3, Group A organism. This strain possessed no M 
protein and was avirulent. In addition the vaccine had been treated with pep- 
sin. The challenge material was extracted from a Type 1, Group A organism. 
The following experiment provides information pertinent to subsequent im- 
munity studies. 
TABLE I 
Immunization  of Rabbits  witk a Group A  Streptococcal  Vaccine.  Index  Values  Following 
Ckallenge wilh a 75p60-3  Fraction* 
Undiluted  1/10 dilution 
Immunized:~  ......................  83  25 
Contro]~ ........................  428  215 
* Index refers to maximum area of lesion in millimeters divided  by time in days required 
for gross appearance. 
6 rabbits per group. 
A comparison was made between the lesion-producing  properties of Group A organisms 
possessing the normal antigenic form of C polysaccharide  and strains derived from these or- 
ganisms which produced an antigenic variant of the polysaecharide (5). Cultures and sonic 
extracts of each organism were treated identically and a comparable amount of each extract, 
based on total nitrogen values, was injected intradermally. 
As may be seen in Table II, there was no significant difference between strains 
possessing the original C polysaccharide and those with the variant form. It 
may be noted also  that  there is no difference between strains  possessing or 
lacking the M  protein. 
According to McCarty (5) immunization of rabbits with organisms possessing 
the  original polysaccharide yields antiserum  giving very little cross-reaction 
with the variant polysaccharide. In view of this one would expect that if the 
resistance displayed in  the  first experiment was  due solely to the antibodies 
against  C  polysaccharide,  there  should  be  no  immune  resistance  displayed 
against the toxic component obtained from a strain producing the variant poly- 
saccharide. Therefore, groups of immunized and control rabbits were challenged 
on one flank with an intradermal injection of the crude sonic extract (36s30-1) 
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flank with a Type 1 organism possessing the variant strain. The animals had 
been immunized with the Type 3 organism as described in the first experiment. 
Table III shows that there is a 19-fold difference in the index between the im- 
TABLE II 
Comparison of Group A  Streptococcal Strains Producing the Original and Variant C 
Polysaccharide 
Strain*  Type  Produce M antigen  Index 
K-43, original C ................. 
K-43, variant C ................. 
C203/42/3, original C ............ 
C203/29/4, original C ............ 
B455,  variant  C  (derived  from 
C203/29 stock) ................ 
Yes 
Yes 
Yes 
No 
No 
428 
517 
267 
280 
447 
* All strains have Type 1 T antigen. 
TABLE III 
Homologous and  Heterologons Challenge of Rabbits Immunized  with Group A  Streptococcal 
Vaccine 
Immunized 
Control 
Ratio 
Index 
No. with relapse 
Total 
Index 
No. with relapse 
Total 
Control index 
Immune index 
Challenge 
Homologous (Grou1~  A 
polysaccharide) 
44 
0/6 
835 
4/6 
19 
Heterologous (variant 
polysaccharide) 
145 
1/6 
5O4 
2/6 
3.5 
mune and control groups in the case of the homologous challenge. There is also 
a difference in the relapses occurring in the two groups. On the other hand there 
is a 3.5-fold difference between the index of the immunized and control animals 
at the sites injected with the heterologous (variant polysaccharide) material, 
This difference is also significant at the 0,01 level when the data is subjected to 
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in the immunized group. Since the toxic component is a very complex molecule 
it is possible that other directive groups besides the C polysaccharide are anti- 
genic. If such directive groups are sufficiently similar in the three strains of or- 
ganisms involved in this experiment, this may explain the small but significant 
degree of resistance against the extract of the variant strain. 
While there is no question that the process of immunization vastly modifies 
the reaction to  this  toxic material,  there remains some doubt regarding the 
completeness of the neutralization possibly due to the fact that the minimal re- 
action seen in the immunized group resulted from the hypersensitive state de- 
veloped by the immunizing procedure. To help resolve this problem a group of 
15 rabbits,  immunized in the same manner,  and 15 control rabbits,  were in- 
TABLE  IV 
Immunization  of Rabbits with Group A  Vaccine and with Group D  Vaccine (Streptococcus 
durans) * 
Immunized (Group A  vaccine) ........... 
Control .............................. 
Immunized (Group D  vaccine) ........... 
Index 
34 
474 
396 
No. with relapse 
Total 
0/4 
2/5 
Persistent plaques 
* Animals were killed at intervals from 3 hours to 35 days after challenge for histological 
comparison of lesions. These figures are from animals kept more than  10 days. 
jected  intradermally  with  0.2  ml.  of  the  same  Type  1  crude  sonic  ex- 
tract  (36s30-1)  as was used in  the previous experiment. The features of the 
lesion observed in the gross in the two groups were comparable to those de- 
scribed in the above experiment. Two animals from each group were killed at 
the following intervals after injection and the lesions examined microscopically: 
3 hours, 12 hours, 24 hours, 5 days, 10 days, 21 days, 35 days.  Table IV com- 
pares the index values for those immune and control animals which were kept 
long enough to observe the development of lesions. Here again, there is a large 
difference (14 X) in the extent of the lesions in the two groups, as well as  the 
absence of exacerbations in  the immune rabbits.  In this experiment another 
group of animals was included which had been immunized, by the same tech- 
nique, with a  vaccine of a  Group D  organism, Streptococcus durans.  This was 
included as an additional control on the specificity of the immunization process. 
It can be seen in Table IV  that there is no difference between the lesions in 
normal animals and those immunized with S. durans. 
The comparative histological studies were in keeping with the gross features. 
Sections of the  lesions  which  developed in  the  control animals  revealed the 
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stages of this reaction (1, 2). Sections of the lesions which developed in the im- 
munized animals and which were fixed 3, 12, and 24 hours after challenge with 
the toxic material, revealed changes comparable to those observed in the con- 
trol animals. It should be noted that the reaction in the immunized group was 
restricted to a small area of the skin as indicated by the size of the lesions as they 
appeared in the gross. 
Sections fixed 5, 10, 21, and 35 days after challenge revealed a marked differ- 
ence between the control and immunized groups. In the immunized groups only 
moderate  evidence  of  a  chronic  reaction  was  noted.  This  consisted of focal 
accumulations  of macrophages  and  lymphocytes.  This  reaction  appeared  to 
gradually subside. In the sections fixed 35 days after challenge only scattered 
single  lymphocytes  and  macrophages  were  noted  in  the  dermal  connective 
tissue which in other respects appeared normal. The sections from the control 
animals which were killed 5,  10,  21,  and 35  days after injection revealed the 
combined acute and chronic inflammatory reaction, the histologic features of 
which have  been described in detail elsewhere (1,  2).  In none of the sections 
studied was there evidence of vascular necrosis or thrombosis which would sug- 
gest the possibility of a  hypersensitivity reaction playing a part in the changes 
observed. 
In Vitro Studies.--Additional evidence that the resistance of immunized ani- 
mals is the result of a  specific immune response directed primarily against the 
C polysaccharide moiety of the toxin, is provided by in vitro studies. 
Both the immunized  and normal animals were  bled from the heart 7 days after the last 
immunizing dose and 48 hours prior to the in vivo challenging injection, and the serum frozen 
at -- 20°C. Group A, Type 3, strain B455 cells were collected from 4 L of broth culture, washed 
2 times, and subjected to 1 hour sonic  vibration. The whole  suspension  was then  dialyzed 
against distilled water for 2 days in the cold room and lyophilized. The B455 strain produces 
the antigenic variant of C polysaccharide and was derived from the same stock as C203/29/4, 
which was the strain used to immunize the rabbits. If we assume that the B455 strain is iden- 
tical with the parent strain in all antigenic moieties except the C polysaccharide,  then it should 
be possible to absorb the immune serum with the variant strain to yield antiserum reacting 
only with C polysaecharide.  Thus, 50 rag. of the lyophilized extract was added to 30 ml. of 
pooled serum from 6 immunized rabbits. The precipitate developing after incubation at 37°C. 
for ~  hour and 4°C. for 6 hours was removed by centrifugation at 2,000 R.p.,s. This absorption 
was repeated 4 times with a total of 250 rag. of extract at which time the supernate gave no 
reaction in a ring precipitate test with the sonic extract of the B455 strain, but still showed a 
good precipitin reaction with the homologous extract as well as with C polysaccharide pre- 
pared by the formamide method. This absorbed serum was then centrifuged  at 140,000 G in 
the Spinco No. 40 rotor for 1 hour to remove the lesion-producing component present in the 
B455 sonic extract (3). Merthiolate was added in a final concentration of 1:10,000 and the 
serum frozen at --20°C. Samples of the absorbed and unabsorbed sera were utilized in the 
Oakley agar gel diffusion technique as described by Deicher (7). 
The data in Table V show that only antibodies against C polysaccharide can 
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purified  electrophoretic  trailing  fraction  showed a  second line  of precipitate 
with  unabsorbed serum,  demonstrating  that  this  fraction  contains  at  least  2 
antigenic components although it is electrophoretically homogeneous. 
Two ml. of the absorbed antiserum was mixed with an equal volume of the purified electro- 
phoretic fraction containing 37 gamma N per ml. These amounts of antigen and antibody were 
TABLE  V 
Comparison of Absorbed and  Unabsorbed Antiserum by the Oakley Agar Diffusion  Technique 
Antigen sample 
Sonic extract of C203/29/4 .................... 
Sonic extract of B455 ....................... 
C polysaccharide (formamide) .................. 
75p60-3 fraction ............................. 
Electrophoretic trailing fraction ................  I 
* No.  of fines of precipitate developing during 
Anti C203/29/4 
4* 
2 
1 
2 
2 
Serum sample 
weeks observation. 
Anti C203/29/4 
absorbed with B455 
1" 
0 
I 
1 
1 
TABLE  VI 
Neutralization  of Purified  Toxin witk Anti Streptococcal Serum Absorbed with  Variant  Cells 
Sample injected 
Antiserum +  toxin* -  supernate .............. 
Normal rabbit serum +  toxin -- supernate ...... 
Saline +  toxin -  supernate ................... 
Antiserum +  toxin -- sediment  resuspended  in 
saline ..................................... 
Index 
3.8 
666 
616 
1.8 
Relapses 
Total animals 
0/6 
6/6 
5/6 
0/6 
* The purified electrophoretic trailing fraction of sonic extract. 
known, from quantitative immunochemical studies, to yield a mixture in relatively great anti- 
body excess (8). Following incubation at 25°C. for ~  hour and 4°C. for 24 hours, the resulting 
precipitate was collected at 2,000 R.V.M. for ~  hour at 2°C.  The precipitate was resuspended 
in saline to the original volume. Similar samples of this electrophoretic fraction were incubated 
with normal rabbit serum and with saline and subjected to identical treatment. Supernate 
ring precipitin tests confirmed the fact that the antiserum-antigen mixture was in antibody 
excess.  Each of 6 rabbits was injected intradermally in 4 sites with samples shown in Table VL 
Each inoculum was calculated to contain 7.4 gamma of toxin N, if no precipitation had oc- 
curred. This was a dose known to consistently produce a good dermal lesion. 
It may  be seen that in terms of the index values and number  of relapses, the 
anti  C  polysaccharide  antibodies completely neutralized  the connective tissue 
toxin. These rabbits were observed almost daily for 100 days and, although re- 302  C POLYSACCHARIDE COMPLEX OF  GROUP A  STREPTOCOCCI 
lapses were observed to occur as late as 80 days after injection at the sites in- 
oculated  with  normal  serum  or  saline  controls,  nothing,  except  a  small 
10 X  10 ram. lesion at 3 sites, developed in areas inoculated with supernate or 
resuspended sediment from the antiserum-antigen mixture. 
As final proof that  antibodies against  the  C  polysaccharide moiety of the 
toxic  molecule  were  responsible  for  neutralization,  inhibition  studies  were 
carried out.  For these experiments the partially purified 75p60-3  fraction was 
used  since it was available in greater amounts  than  the more highly purified 
electrophoretic trailing fraction.  The  agar  diffusion experiments indicate  the 
TABLE VII 
Titration  of Neutralizing  Capacity  of Absorbed  Antiserum* 
Absorbed antiserum 24 hrs. at  Normal serum 24 hrs. at  Absorbed antiserum, ~  hr. 
4°C. plus centrifugation  4°C. plus centrifugation  at 4* C. not centrifuged 
Serum dil.  Index__  Relapse  Index  Av. time  Relapses 
1/1 
1/2 
1/4 
1/8 
1/16 
1/32 
1/64 
1/128 
1/256 
1/512 
0 
0 
0 
0 
10 
8 
116 
197 
171 
175 
Av. time 
days~ 
16 
4 
14.7 
8.4 
8.7 
8.5 
0 
0 
0 
0 
1/6 
0 
0 
2/6 
2/6 
2/6 
I ldex  A' 
t89  [ 
.~82  I 
.~47  [ 
152  I 
t57 
'. ti ne  R ,'lap 
Iay~ "~ 
6. ~.  3/~ 
8.~  ~./~ 
~. ~  ~./~ 
6 .,~  L/~ 
5.'~  t/~ 
m 
5 
8 
10 
7 
29 
37 
85 
days$ 
7 
14 
13 
19.7 
13.7 
17.7 
12.6 
0 
0 
0 
0 
0 
0 
2/5 
* Anti  C203/29/4  absorbed with  sonic  extract  of  B455. 
:~ Average time in days required for first gross appearance of lesion. 
75p60  fraction plus absorbed antiserum also represents a  homogeneous  anti- 
gen-antibody system and should be suitable for these experiments. The activity 
of this crude preparation is more difficult to predict on a weight basis and there- 
fore a  titration  of lesion-producing activity was  carried out  with  an  aliquot 
of the 75p60 preparation. 
Each dilution was injected into 6 rabbits at 1 of 4 sites on each animal, and the highest dilu- 
tion producing a consistent lesion within 7 days was determined. This dilution contained 15 
gamma N per ml. Serial twofold dilutions of absorbed antiserum were mixed with an equal 
volume of the proper dilution of 75p60-2 fraction, incubated at 25°C. for ~  hour and at 4°C. 
for 24 hours, centrifuged at 2,000 x.P.~, at 2°C. and the superuate injected intradermally into 
6 rabbits at 1 of 4 sites on each animal. Normal rabbit serum samples in dilutions of 1/1 to 1/16 
were likewise mixed with the toxin and teated similarly. The order of injection of the dilutions 
of immune and control serum was rotated in order to avoid any possible effect an injection 
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No difference in the development of a lesion was noted, regardless of whether 
antiserum undiluted or in a  1/512 dilution was injected on the same flank with 
a normal serum control site. Therefore, diffusion of antibody away from a site 
of injection did not occur in sufficient concentration  to influence an adjacent 
site of inoculation. 
As mentioned above the resuspended antigen-antibody precipitate was shown 
to have no lesion-producing capacity. From this fact it was concluded that the 
antibody was not merely removing the toxin by precipitation, but was actually 
neutralizing it. As a  further test of this conclusion a  second titration of anti- 
serum was run concomitantly with  that described above, with  the difference 
TABLE VIII 
Inhibition  of  Neutralisagion  by  Angi-C  Polysaccharid~ 
Sample*  N in precipitate  Inhibition of  per ml. serum  precipitate  Supemate tests  Index 
Antiserum 
Antiserum plus N-acetyl-D- 
glucosamine 
Antiserum plus C polysacchar- 
ide (formamide) 
Normal rabbit serum plus N- 
acetyl-D-glucosamine 
/$g. 
116 
69 
7.8 
pGrg~ng 
4O 
93 
Antibody excess 
Neg.-antibody 
and antigen 
Neg.-antibody 
and antigen 
Antigen excess 
8 
22 
124 
171 
* Anti C203/29/4 absorbed with sonic extract of strain B455. Toxin was 75p60-3 fraction. 
that the antibody-antigen mixture was incubated at 25°C. for 1~ hour and 4°C. 
for 1/~  hour and  the  whole  suspension  injected without  centrifugation of the 
precipitate. The results comparing the shorter incubation with long incubation 
plus removal of precipitate are shown in Table VII. It is evident  that  with 
dilutions of this serum above 1/32 the antiserum is much more effective ff the 
precipitate is not removed before injection. It may also be seen that the index 
values increase in apparent proportion to the serum dilution when the precipi- 
tate is not removed. On theother hand, there isa precipitousdrop in neutralizing 
capacity of the serum above 1/32  dilution when the precipitate is removed by 
centrifugation.  This  correlates  very well  with quantitative determinations of 
the precipitate (8). These results are interpreted to mean that some of the anti- 
body which is removed in the precipitate after 24 hours incubation is still capable 
of reacting with more toxin; therefore, if the whole antigen-antibody suspension 
is injected, greater neutralizing activity of the antiserum is realized. 
From this data, a 1/16 dilution of antiserum was selected for studies on inhibition of anti- 
body neutralization. N-acetyl-D-glucosamine  was added to one aliquot of absorbed serum to 
give a final molarity of 0.125. A second aliquot was absorbed with the C polysaccharide  hapten 304  C  POLYSACCHARIDE  COMPLEX  OF  GROUP  A  STREPTOCOCCI 
using the formamide extraction method described by Zittle and Harris  (9). This relatively 
pure preparation contained 5.1 per cent N  and showed only 1 line of precipitate with the un- 
absorbed antiserum in the Oakley technique. The antiserum was absorbed 3 times with this 
material by incubation at 37°C.  for ~  hour followed by 6 hours at 4°C. and removal of the 
precipitate at 2,000 ~.P.~. This absorbed serum showed neither excess C polysaccharide nor 
antibody by the ring precipitin test. A third aliquot of antiserum received no further treat- 
ment. The control consisted of normal rabbit serum plus 0.125 M N-acetyl-D-glucosamine. An 
equal volume of the same concentration of the 75p60-3 fraction used previously was added to 
each sample and incubated at 25°C.  for ~  hour and 4°C. for 22 hours after which they were 
centrifuged at 2,000 x.P.g. The precipitates were washed 2 times with saline and total N  de- 
termined. Each of these samples, with antigen and serum controls, was run in duplicate. These 
results and ring precipitin tests on the supernates are shown in Table VIII. 
McCarty has shown that N-acetylglucosamine is the principal directive group 
of the C polysaccharide (10). The degree of inhibition of precipitation produced 
with this sugar,  as well as with the C polysaccharide hapten,  clearly demon- 
strates that the immune precipitation of the toxic material is due to antibodies 
reacting specifically with C polysaccharide. 
Each of  the  supernates  from  these  inhibition  studies was  injected into 6 
rabbits. The inhibition of neutralizing capacity of the antiserum,  while under- 
standably not as clear cut as the quantitative precipitin data, shows that the 
specific  neutralizing  antibody is directed against  the group  specific  C  poly- 
saccharide. 
DISCUSSION 
These studies clearly demonstrate that antibodies against C polysaccharide 
can specifically neutralize the capacity of the toxic cellular component of Group 
A streptococci to produce chronic remittent and intermittent lesions of dermal 
connective  tissue.  The  unique  histological  features of  the connective tissue 
lesion are greatly modified  in rabbits actively immunized with a streptococcal 
vaccine. The antiserum from these rabbits, absorbed to contain only antibodies 
against  the  group-specific  C  polysaccharide,  will  precipitate and specifically 
neutralize  the toxic material  in vitro.  Finally,  this immune precipitation and 
neutralization can be inhibited by formamide-isolated C polysaccharide and by 
N-acetylglucosamine, the principal directive group of the polysaccharide antigen. 
These findings provide further proof that the group-specific C polysaccharide 
is an important component of this toxic material.  It should be noted, however 
that  the isolated C  polysaccharide hapten  with a  molecular weight of about 
8,000,  prepared  by formamlde  extraction,  has  no toxic activity (4).  As one 
would expect from the chemical composition of the streptococcal cell wall (10, 
11),  purified  cell  wall  suspensions  will  produce the  experimental  connective 
tissue lesion, although they are less active on a weight basis than particles with 
dimensions  intermediate  between the hapten  and  recognizable  cell walls (4). 
Thus, toxic activity is associated with a rather limited range of particle size of 
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There is considerable  evidence relating the Group A streptococci  to certain 
disease states which are characterized by widespread involvement of connective 
tissue.  The evidence  relating these organisms  to rheumatic fever  is very im- 
pressive. However,  the mechanism by which Group A streptococci produce  the 
tissue  changes of rheumatic fever observed  in a  small per cent of individuals 
infected with these organisms, has not been made clear in spite of a great deal 
of speculation.  Some form of hypersensitivity has been most frequently  invoked 
in an attempt to explain the most prominent features of rheumatic fever and 
other connective tissue diseases which include: (a) fibrinoid necrosis of connective 
tissue,  (b)  relapses  associated  with sterile  lesions, and (c)  a  prolonged course 
(12). A critical review of the data supporting the hypersensitivity  concept, such 
as that presented by MacLeod (13), emphasizes the fact that it is based wholly 
on indirect evidence. 
The properties of the toxic C polysaccharide complex described here; the gross 
and microscopic features of the experimental  lesion produced with this toxic 
material; and the observations on the course of the experimental  lesion, indicate 
that this toxic component of Group A streptococci should be investigated as a 
possible factor in the pathogenesis of the non-suppurative sequelae associated 
with these organisms.  This concept,  that the lesions associated  with the non- 
suppurative  sequelae  are  the  result of a  Group A streptococcal  component 
having a direct toxic action on connective  tissue, is in distinct contrast to the 
concept of many investigators that hypersensitivity as a result of an immune 
response to streptococcal  antigens is the primary cause of these tissue changes. 
One of the properties  of C polysaccharide  relevant to this discussion is its 
poor antigenicity under conditions of natural infection (14-16).  MacLeod (13) 
postulates that if a streptococcal  toxin is involved in rheumatic fever it would 
have to be a poor antigen to account for the failure of one attack to confer 
immunity against subsequent attacks. Rantz and Randall (15) have shown that 
detectable antibodies against C polysaccharide  developed  in only 6 per cent 
of patients infected with Group A hemolytic streptococci.  This was in contrast 
to a significant increase in antistreptolysin O in over 80 per cent of the group. 
Of the 298 cases which were included in that study, 44, or 15 per cent, had some 
non-suppurative complication  and 30,  or 63  per cent of these,  displayed no 
anti-C antibodies.  A most interesting observation was that of the 13 compli- 
cations in their category of "late fever" none developed anti-C, and none of the 
6 complications in the category of "carditis with late fever" showed any anti- 
body against C polysaccharide. 
In a similar study Rothbard et al. (16) reported that of 83 acute streptococcal 
infections occurring in 71 patients, 34 were followed by rheumatic fever. Only 
4 of the rheumatic fever group had detectable anti-C antibodies. 
If one assumes that the toxic C polysaccharide complex plays a role in rheu- 
matic fever,  then the studies of Rantz and Randall  (15) and Rothbard et al. 
(16), along  with the investigations reported here,  could  account for the fact 306  C  POLYSACCHARIDE  COMPLEX  OP  GROUP  A  STREPTOCOCCI 
that remission of the rheumatic state is not associated with evidence of increased 
resistance to the disease. These data could also help explain the apparent ability 
of the toxic substance to remain in the tissue for relatively long periods of time 
and to continue to produce injury in the experimental lesion (1).  Relative to 
this idea is  the observation  that  repeated  injection of the toxic material in 
rabbits, in the doses used to produce a lesion, has no effect on the evolution of 
the lesions  (2).  It  is only when rabbits  have  been  hyperimmunized with a 
vaccine to induce production of detectable C  polysaccharide precipitins that 
modification of the lesion is observed. 
There appears, therefore, to be sufficient similarity between th  e experimental 
model produced with the toxic complex of group-specific C polysaccharide and 
certain connective tissue diseases related to Group A streptococci, to warrant 
further investigations based on this experimental approach. 
SUMMARY 
A macromolecular complex of C  polysaccharide and peptide derived from 
Group  A  streptococcal  cells  produces  a  multinodular, remittent, and  inter- 
mittent lesion of dermal connective tissue following a single intradermal injec- 
tion.  This lesion is greatly modified, both  in  the gross and microscopically, 
in rabbits hyperimmunized with a Group A streptococcal vaccine. 
The immune serum, absorbed to yield only antibodies against C polysaccha- 
ride as indicated by agar diffusion techniques, will precipitate and neutralize 
the toxic material. This neutralization and in vitro precipitation can be inhibited 
with formamide-isolated C  polysaccharide hapten  and  with N-acetylglucos- 
amine, the primary directive group of this antigen. This clearly demonstrates 
that antibodies against the group-specific C polysaccharide are responsible for 
resistance to this toxic material. 
The immunological and other properties of the toxic C polysaccharide com- 
plex, the fact that it is a product of Group A streptococci, the gross and micro- 
scopic features of the experimental lesion produced with this substance, and 
the observations on the chronic course of the experimental lesion, indicate that 
this toxic material should be investigated as a  possible  factor in the patho- 
genesis of the non-suppurative sequelae associated with Group A streptococci. 
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